Stenocare A/S (XSAT:STENO) EV-to-Revenue : 66.17 (As of May. 07, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Stenocare A/S EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Stenocare A/S's enterprise value is kr271.55 Mil. Stenocare A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr4.10 Mil. Therefore, Stenocare A/S's EV-to-Revenue for today is 66.17.

The historical rank and industry rank for Stenocare A/S's EV-to-Revenue or its related term are showing as below:

XSAT:STENO' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.59 Med: 70.62 Max: 1885.62
Current: 24.67

During the past 6 years, the highest EV-to-Revenue of Stenocare A/S was 1885.62. The lowest was 6.59. And the median was 70.62.

XSAT:STENO's EV-to-Revenue is ranked worse than
92.97% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs XSAT:STENO: 24.67

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-07), Stenocare A/S's stock price is kr30.00. Stenocare A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.46. Therefore, Stenocare A/S's PS Ratio for today is 65.22.

Stenocare A/S EV-to-Revenue Historical Data

The historical data trend for Stenocare A/S's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare A/S EV-to-Revenue Chart

Stenocare A/S Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

49.53

68.26

24.82

12.31

Stenocare A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															25.31	12.66	9.96	12.31	-

Competitive Comparison of Stenocare A/S's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare A/S's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stenocare A/S's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare A/S's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Stenocare A/S's EV-to-Revenue falls into.

Stenocare A/S EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Stenocare A/S's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	271.553	/	4.104
	=	66.17

Stenocare A/S's current Enterprise Value is kr271.55 Mil.
Stenocare A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.10 Mil.

Stenocare A/S (XSAT:STENO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Stenocare A/S's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	30.00	/	0.46
	=	65.22

Stenocare A/S's share price for today is kr30.00.
Stenocare A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.46.

Stenocare A/S EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Stenocare A/S's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Stenocare A/S (XSAT:STENO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare A/S (XSAT:STENO) » Definitions » EV-to-Revenue

Traded in Other Exchanges

STENO:Denmark S7C:Germany

Address

Nyholmsvej 4, Randers NØ, DNK, 8930

Website

https://www.stenocare.com

Stenocare A/S is a Danish company engaged in the development, imports and marketing of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmark, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark. The company's product offering includes medical cannabis oil like CBD DROPS STENOCARE, 1: 1 DROPS STENOCARE, and THC DROPS STENOCARE.

Stenocare A/S (XSAT:STENO) Headlines

No Headlines